Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells

Journal of Cellular Physiology

Volumn 210, Issue 3, 2007, Pages 766-773

  Yang, Heping ^a   Magilnick, Nathaniel ^a   Noureddin, Mazen ^a   Mato, José M ^b   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CIC BIOGUNE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; CELL CONTACT; CELL CYCLE REGULATION; CELL DENSITY; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; CYCLIN A GENE; ENZYME ACTIVATION; ESSENTIAL GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; GROWTH STIMULATION; HGF GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAT1A GENE; MAT2A GENE; MAT2BETA GENE; NUCLEOTIDE SEQUENCE; ONCOGENE C MET; P21 GENE; P27 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA GENE;

CARCINOMA, HEPATOCELLULAR; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; METHIONINE ADENOSYLTRANSFERASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MET; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33846566813     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20891     Document Type: Article

References (39)

1. Bell A, Chen Q, DeFrances MC, Michalopoulos GK, Zarnegar R. 1999. The five amino acid-deleted isoform of hepatocytes growth factor promotes carcinogenesis in transgenic mice. Oncogene 18:887-895.
2. Cai J, Sun W, Hwang JJ, Stain S, Lu SC. 1996. Changes in S-adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance. Hepatology 24:1090-1097.
3. Cai J, Mao Z, Hwang JJ, Lu SC. 1998. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 58:1444-1450.
4. Chen L, Zeng Y, Yang HP, Lee TD, French SW, Corrales FJ, García-Trevijano ER, Avila MA, Mato JM, Lu SC. 2004. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. Int J Cancer 87:644-649.
5. Cioce V, Csaky KG, Chan AML, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS. 1996. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem 271:13110-13115.
6. Ebisuya M, Kondoh K, Nishida E. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity: Mechanisms for providing signaling specificity. J Cell Sci 118:2997-3002.
7. Gil B, Casado M, Pajares M, Boscá L, Mato JM, Martín-Sanz P, Alvarez L. 1996. Differential expression pattern of methionine adenosyltransferase isoenzymes during rat liver development. Hepatology 24:876-881,
8. Halim A, LeGros L, Geller A, Kotb M. 1999. Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells. J Biol Chem 274:29720-29725.
9. 1 in HepG2 hepatoma cells. J Biol Chem 280:31548-31556.
10. Huang ZZ, Mao Z, Cai J, Lu SC. 1998. Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol 38:G14-21.
11. Huang ZZ, Mato JM, Kanel G, Lu SC. 1999. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression. Hepatology 29:1471-1468.
12. Jiang W, Hiscox S, Matsumoto K, Nakamura T. 1999. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Criut Rev Oncol-Hematol 29:209-248.
13. Jiang Y, Xu W, Lu J, He F, Yang X. 2001. Invasiveness of hepatocellular carcinoma cell lines: Contribution of hepatocytes growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Comm 286:1123-1130.
14. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, Chou JY, Cantoni GL. 1997. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet 13:51-52.
15. Kumatori A, Nakamura T, Ichihara A. 1991. Cell-density dependent expression of the c-myc gene in primary cultured rat hepatocytes. Biochem Biophys Res Comm 178:480-485.
16. Latasa MU, Boukaba A, GarcÌa-Trevijano ER, Torres L, Rodríguez JL, Caballería, Lu SC, Lüpez-Rodas G, Franco L, Mato JM, Avila MA. 2001. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes. Role in liver regeneration. Int J Cancer 10.1096/fj.00-0556fje, March.
17. Lee HS, Huang AM, Huang GT, Yang PM, Chen PJ, Sheu JC, Lai MY, Lee SC, Chou CK, Chen DS. 1998. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells. J Biochem Sci 5:180-184,
18. Liu ML, Mars WM, Michalopoulos GK. 1995. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis 16:841-843.
19. Lu SC. 2000. Molecule in focus: S-adenosylmethionine. Int J Biochem Cell Biol 32:391-395.
20. Lu SC, Ge J. 1992. Loss of suppression of GSH synthesis under low cell density in primary cultures of rat hepatocytes. Am J Physiol 263:C1181-1189.
21. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, Kanel G, Mato JM. 2001. Methionine adenosyltransferase 1 a knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 98:5560-5565.
22. Machide M, Hashigasako A, Matsumoto K, Nakamura T. 2006. Contact inhibition of hepatocyte growth regulated by functional association of the c-met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. J Biol Chem 281:8765-8772.
23. Martínez-Chantar ML, Garcia-Trevijano ER, Latasa MU, Martin-Duce A, Fortes P, Caballeria J, Avila MA, Mato JM. 2003. Methionine adenosyltransferase II β subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology 124:940-948.
24. Mato JM, Corrales FJ, Lu SC, Avila MA. 2002. S-Adenosylmethionine: A control switch that regulates liver function. FASEB J 16:15-26.
25. Matteucci E, Castoldi R, Desiderio MA. 2001. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells. J Cell Physiol 186:387-396.
26. Michalopoulos GK, DeFrances MC. 1997. Liver regeneration. Science 276:60-66.
27. Nakamura T, Yoshimoto K, Nakayama Y, Tomita Y, Ichihara A. 1983. Reciprocal modulation of growth and differentiated functions of mature rat hepatocytes in primary culture by cell-cell contact and cell membranes. Proc Natl Acad Sci USA 80:7229-7233.
28. Nakamura T, Nakayama Y, Ichihara A. 1984. Reciprocal modulation of growth and liver functions of mature rat hepatocytes in primary culture by an extract of hepatic plasma membranes. J Biol Chem 259:8056-8058.
29. Okano J, Shiota G, Matsumoto K, Yasui S, Kurimasa A, Hisatome I, Steinberg P, Murawaki Y. 2003. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 309:298-304.
30. Pañeda C, Gorospe I, Herrera B, Nakamura T, Febregat I, Varela-Nieto I. 2002. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA upregulation. Hepatology 35:1381-1391.
31. Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G, LaRochelle WJ. 1996. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 7:1513-1523.
32. Santoni-Rugui E, Preisegger KH, Kiss A, Audolfsson T, Shiota G, Schmidt EV, Thorgeirsson SS. 1996. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 93:9577-9582.
33. Takehara T, Mutsumoto K, Kamamura T. 1992. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J Biochem 112:330-334.
34. Tavian D, DePetro G, Benetti A, Portolani N, Giulini SM, Barlati S. 2000. uPA and c-Met mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocelluar carcinoma. Int J Cancer 87:644-649.
35. Tsukada Y, Miyazawa K, Kitamura N. 2001. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 276:40968-40976.
36. Tsukada Y, Tanaka T, Miyazawa K, Kitamura N. 2004. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2. J Biochem 136:701-709.
37. Wang SY, Chen B, Zhan YQ, Xu WX, Li CY, Yang RF, Zheng H, Yue PB, Larsen SH, Sun HB, Yang X. 2004. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. J Hepatol 41:267-273.
38. Yaono M, Hasegawa R, Mizoguchi Y, Futakuchi M, Nakamura T, Ito N, Shirai T. 1995. Hepatocyte growth factor enhancement of preneoplastic hepatic foci development in rats treated with diethylnitrosamine and N-ethyl-N- hydroxyethylnitrosamine. Jap J Cancer Res 86:718-723.
39. Zarnegar R, Michalopoulos GK. 1995. The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129:1177-1180.